Clin2
NCT07219888Likely a fitEnrolling by invitation

Comparing suzetrigine and oxycodone for knee replacement pain

Osteoarthritis (OA) of the Knee

Part of Bones, joints & muscles clinical trials.

This study compares a new pain medicine called suzetrigine with a commonly used opioid, oxycodone, for pain after a knee replacement. The goal is to see which works better and has fewer side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
140 people
Ages
21 years to 89 years
Study type
Interventional

Who can take part

  • You are between 21 and 89 years old.
  • You are scheduled for a total knee replacement because of osteoarthritis.
  • You can read and speak English.
  • You are not allergic to suzetrigine.
  • You are not pregnant or nursing.
  • You have not taken any opioid pain medicine in the last 90 days.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07357376Not yet recruiting· Phase 3
Study of suzetrigine for pain after knee replacement surgery

This study tests a new pain medicine called suzetrigine for people having a first-time total knee replacement. The goal is to see if it helps control pain after surgery.

NCT07624526Not yet recruiting· Phase 4
Suzetrigine to Reduce Pain and Opioid Use After Knee Surgery

This study tests whether a new pain medication called suzetrigine, when combined with other pain-management strategies, can reduce pain and the need for opioids after total knee replacement surgery. The goal is to help patients recover comfortably while using fewer opioids.

Atlanta, Georgia
NCT07548385Recruiting· Phase 3
New pain medicine for after knee replacement surgery

This study tests a new medication called suzetrigine to help manage pain after knee replacement surgery. The goal is to see if it reduces pain and discomfort better than current treatments.

New York, New York
NCT07226700Recruiting· Phase 3
Suzetrigine for pain after hip replacement surgery

This study tests an investigational pain medicine called suzetrigine to see how well it controls pain after total hip replacement surgery. It is for adults 18–80 who are having a first-time hip replacement and can receive spinal anesthesia.

New York, New York
NCT07672015Recruiting· Phase 4
Testing a new pain drug in surgery patients at risk for opioid dependence

This trial tests a new painkiller called suzetrigine for post-surgery pain. It's designed for people whose medical records suggest they may have a higher chance of needing strong painkillers (opioids) long after surgery. We want to see if suzetrigine works better at preventing that.

La Jolla, California
NCT07355166Not yet recruiting· Phase 4
Non-opioid vs opioid painkiller for ACL surgery recovery

This study compares a new non-opioid painkiller (suzetrigine) to standard opioid pain medicines for pain relief after ACL surgery. It aims to find a safer, effective alternative without the risks of opioids.

Hear when a new Osteoarthritis (OA) of the Knee trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.